Herpes simplex type-1 virus-based vectors for gene therapy

T. Ichikawa, Y. Saeki, T. Tamiya, E. A. Chiocca, T. Ohmoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recent advances in recombinant nucleic acid technologies and the understanding of the molecular biology of diseases provide the basis for gene therapy's ability to impact on the clinical practice of medicine. Herpes simplex virus type 1 (HSV-1) has features that make it suitable as a vector for gene therapy. These properties include: 1) wide host range and high efficiency of gene transfer; 2) large transgene capacity which is provided by deletion of genes unnecessary for viral replication; 3) unique ability of entering a state of latency in neurons; 4) specific oncolytic effect of some mutants by deletion of certain early genes. Three types of vectors designed for gene therapy have been developed from this virus, termed replication-defective vectors, replication-conditional vectors and amplicon vectors. In this review, we describe the recent advances in HSV-1-based vector systems and their applications for gene therapy.

Original languageEnglish
Pages (from-to)822-827
Number of pages6
JournalNihon rinsho. Japanese journal of clinical medicine
Volume58
Issue number4
Publication statusPublished - 2000

Fingerprint

Human Herpesvirus 1
Genetic Therapy
Viral Genes
Host Specificity
Clinical Medicine
Gene Deletion
Virus Replication
Transgenes
Nucleic Acids
Genes
Molecular Biology
Technology
Neurons

Cite this

Ichikawa, T., Saeki, Y., Tamiya, T., Chiocca, E. A., & Ohmoto, T. (2000). Herpes simplex type-1 virus-based vectors for gene therapy. Nihon rinsho. Japanese journal of clinical medicine, 58(4), 822-827.

Herpes simplex type-1 virus-based vectors for gene therapy. / Ichikawa, T.; Saeki, Y.; Tamiya, T.; Chiocca, E. A.; Ohmoto, T.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 58, No. 4, 2000, p. 822-827.

Research output: Contribution to journalArticle

Ichikawa, T, Saeki, Y, Tamiya, T, Chiocca, EA & Ohmoto, T 2000, 'Herpes simplex type-1 virus-based vectors for gene therapy', Nihon rinsho. Japanese journal of clinical medicine, vol. 58, no. 4, pp. 822-827.
Ichikawa T, Saeki Y, Tamiya T, Chiocca EA, Ohmoto T. Herpes simplex type-1 virus-based vectors for gene therapy. Nihon rinsho. Japanese journal of clinical medicine. 2000;58(4):822-827.
Ichikawa, T. ; Saeki, Y. ; Tamiya, T. ; Chiocca, E. A. ; Ohmoto, T. / Herpes simplex type-1 virus-based vectors for gene therapy. In: Nihon rinsho. Japanese journal of clinical medicine. 2000 ; Vol. 58, No. 4. pp. 822-827.
@article{3e0606db2670478d8aff5c62537a30e6,
title = "Herpes simplex type-1 virus-based vectors for gene therapy",
abstract = "Recent advances in recombinant nucleic acid technologies and the understanding of the molecular biology of diseases provide the basis for gene therapy's ability to impact on the clinical practice of medicine. Herpes simplex virus type 1 (HSV-1) has features that make it suitable as a vector for gene therapy. These properties include: 1) wide host range and high efficiency of gene transfer; 2) large transgene capacity which is provided by deletion of genes unnecessary for viral replication; 3) unique ability of entering a state of latency in neurons; 4) specific oncolytic effect of some mutants by deletion of certain early genes. Three types of vectors designed for gene therapy have been developed from this virus, termed replication-defective vectors, replication-conditional vectors and amplicon vectors. In this review, we describe the recent advances in HSV-1-based vector systems and their applications for gene therapy.",
author = "T. Ichikawa and Y. Saeki and T. Tamiya and Chiocca, {E. A.} and T. Ohmoto",
year = "2000",
language = "English",
volume = "58",
pages = "822--827",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "4",

}

TY - JOUR

T1 - Herpes simplex type-1 virus-based vectors for gene therapy

AU - Ichikawa, T.

AU - Saeki, Y.

AU - Tamiya, T.

AU - Chiocca, E. A.

AU - Ohmoto, T.

PY - 2000

Y1 - 2000

N2 - Recent advances in recombinant nucleic acid technologies and the understanding of the molecular biology of diseases provide the basis for gene therapy's ability to impact on the clinical practice of medicine. Herpes simplex virus type 1 (HSV-1) has features that make it suitable as a vector for gene therapy. These properties include: 1) wide host range and high efficiency of gene transfer; 2) large transgene capacity which is provided by deletion of genes unnecessary for viral replication; 3) unique ability of entering a state of latency in neurons; 4) specific oncolytic effect of some mutants by deletion of certain early genes. Three types of vectors designed for gene therapy have been developed from this virus, termed replication-defective vectors, replication-conditional vectors and amplicon vectors. In this review, we describe the recent advances in HSV-1-based vector systems and their applications for gene therapy.

AB - Recent advances in recombinant nucleic acid technologies and the understanding of the molecular biology of diseases provide the basis for gene therapy's ability to impact on the clinical practice of medicine. Herpes simplex virus type 1 (HSV-1) has features that make it suitable as a vector for gene therapy. These properties include: 1) wide host range and high efficiency of gene transfer; 2) large transgene capacity which is provided by deletion of genes unnecessary for viral replication; 3) unique ability of entering a state of latency in neurons; 4) specific oncolytic effect of some mutants by deletion of certain early genes. Three types of vectors designed for gene therapy have been developed from this virus, termed replication-defective vectors, replication-conditional vectors and amplicon vectors. In this review, we describe the recent advances in HSV-1-based vector systems and their applications for gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0034169564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034169564&partnerID=8YFLogxK

M3 - Article

C2 - 10774201

AN - SCOPUS:0034169564

VL - 58

SP - 822

EP - 827

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 4

ER -